At Bath ASU, we believe that continuous improvement is key to delivering the highest quality products and the safest practices for our customers.
Today, we’re pleased to share an important update to our IV manufacturing process, one which that underscores our commitment to safety and efficiency.
Traditionally, our operations have relied on two primary empty IV bags.
These bags use a needle entry port exclusively for drug additions.
Featuring a needle-free injection port, these clear and flexible bags have also played a key role in our production.
Recent enhancements, such as the introduction of Freeflex+ Needleless Bags for both NaCl and Glucose solutions across all sizes, have significantly reduced the use of needle ports.
This development has significantly reduced the number of needles used during manufacturing, and therefore significantly reduce risk to operator safety as well as reducing the occurrence of defects
Despite the improvements, we identified some challenges that needed addressing:
The need to remove needles from the manufacturing process with an additional benefit to reduce the rate of defects and enhance manufacturing capability
Supply Constraints: Securing these bags in all required volumes has proven challenging.
These issues not only elevate the risk to operator injury, but also contribute to an increased rate of defects, which could potentially impact both patient safety and the overall efficiency of our operations.
To overcome these challenges, we are pleased to introduce SecureFill® Bags. This new solution is designed to address the limitations of our existing systems, offering several key benefits:
SecureFill® Bags come equipped with a needle-free injection port, reducing the risk of operator injury and streamlining the drug addition process. After filling, the needless fill port can be covered by a red Freeflex+ protective cap.
Made from clear PolyOlefin (PO) material, these bags allow for easy inspection and provide a reliable view of the contents, ensuring the highest quality standards.
Available in 50ml, 100ml, 250ml, and 500ml sizes, SecureFill® Bags are tailored to meet a wide range of clinical requirements.
These bags are compatible with the existing FK Freeflex+ protective caps, allowing for a smooth transition without disrupting current operations.
By transitioning to SecureFill® Bags, we are set to achieve a range of benefits that directly enhance our service to customers:
The needle-free design minimizes the risks associated with traditional needle-based drug additions, ensuring a safer environment for both operators and patients.
The simplification of the filling process and construction of the new bag is expected to significantly lower the defect rate, thereby ensuring that only the highest quality products reach you.
The clear PO material facilitates easy visual inspection, reinforcing our commitment to quality and reliability in every bag produced.
Drug stability assessments in PO material have demonstrated excellent compatibility, affirming SecureFill® Bags as a robust and dependable solution.
Below is a snippet of the products impacted by this change:
If you have any questions about this change, please complete the form below and one of our team will respond.
